These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mimosa pudica seed mucilage: isolation; characterization and evaluation as tablet disintegrant and binder. Ahuja M, Kumar A, Yadav P, Singh K. Int J Biol Macromol; 2013 Jun; 57():105-10. PubMed ID: 23500434 [Abstract] [Full Text] [Related]
4. Formulation and evaluation of Ficus glomerata mucilage sustained release matrix tablets of gliclazide. Kumar CS, Reddy-Budideti KK, Battula SP, Ayyavala CS. Pak J Pharm Sci; 2011 Jul; 24(3):399. PubMed ID: 21715275 [Abstract] [Full Text] [Related]
5. Evaluation of Plantago major L. seed mucilage as a rate controlling matrix for sustained release of propranolol hydrochloride. Saeedi M, Morteza-Semnani K, Sagheb-Doust M. Acta Pharm; 2013 Mar; 63(1):99-114. PubMed ID: 23482316 [Abstract] [Full Text] [Related]
6. Development of novel diclofenac potassium controlled release tablets by wet granulation technique and the effect of co-excipients on in vitro drug release rates. Shah S, Khan GM, Jan SU, Shah K, Hussain A, Khan H, Khan H, Khan H, Khan KA. Pak J Pharm Sci; 2012 Jan; 25(1):161-8. PubMed ID: 22186325 [Abstract] [Full Text] [Related]
7. Evaluation of xanthan and highly substituted galactomannan from M. scabrella as a sustained release matrix. Ughini F, Andreazza IF, Ganter JL, Bresolin TM. Int J Pharm; 2004 Mar 01; 271(1-2):197-205. PubMed ID: 15129986 [Abstract] [Full Text] [Related]
8. Hydroxyethyl Pachyman as a novel excipient for sustained-release matrix tablets. Zhou X, Wang P, Wang J, Liu Z, Hong X, Xiao Y, Liu P, Hu X. Carbohydr Polym; 2016 Dec 10; 154():1-7. PubMed ID: 27577889 [Abstract] [Full Text] [Related]
9. Soluble filler as a dissolution profile modulator for slightly soluble drugs in matrix tablets. Dvorácková K, Rabisková M, Masteiková R, Muselík J, Krejcová K. Drug Dev Ind Pharm; 2009 Aug 10; 35(8):930-40. PubMed ID: 19274510 [Abstract] [Full Text] [Related]
10. An in vitro evaluation of fenugreek mucilage as a potential excipient for oral controlled-release matrix tablet. Nokhodchi A, Nazemiyeh H, Khodaparast A, Sorkh-Shahan T, Valizadeh H, Ford JL. Drug Dev Ind Pharm; 2008 Mar 10; 34(3):323-9. PubMed ID: 18363148 [Abstract] [Full Text] [Related]
11. Development and evaluation of Ketoprofen sustained release matrix tablet using Hibiscus rosa-sinensis leaves mucilage. Kaleemullah M, Jiyauddin K, Thiban E, Rasha S, Al-Dhalli S, Budiasih S, Gamal OE, Fadli A, Eddy Y. Saudi Pharm J; 2017 Jul 10; 25(5):770-779. PubMed ID: 28725150 [Abstract] [Full Text] [Related]
12. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium. Savaşer A, Ozkan Y, Işimer A. Farmaco; 2005 Feb 10; 60(2):171-7. PubMed ID: 15752476 [Abstract] [Full Text] [Related]
13. Controlled-release cellulose esters matrices for water-soluble diclofenac sodium: compression and dissolution studies. Obeidat WM, Alzoubi NM. Pharmazie; 2014 Feb 10; 69(2):96-103. PubMed ID: 24640597 [Abstract] [Full Text] [Related]
15. The effect of excipients on the release kinetics of diclofenac sodium and papaverine hydrochloride from composed tablets. Kasperek R, Trebacz H, Zimmer Ł, Poleszak E. Acta Pol Pharm; 2014 Feb 10; 71(3):439-49. PubMed ID: 25265824 [Abstract] [Full Text] [Related]
16. Preparation and in-vitro in-vivo evaluation of sustained release matrix diclofenac sodium tablets using PVP-K90 and natural gums. Iqbal Z, Khan R, Nasir F, Khan JA, Rashid A, Khan A, Khan A. Pak J Pharm Sci; 2011 Oct 10; 24(4):435-43. PubMed ID: 21959802 [Abstract] [Full Text] [Related]